<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="nvaf-governance-evidence-v1.2.files/filelist.xml">
<link rel=Edit-Time-Data href="nvaf-governance-evidence-v1.2.files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Fernando, Prabhath (RJE) UHNM</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Fernando, Prabhath (RJE) UHNM</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>8</o:TotalTime>
  <o:LastPrinted>2026-01-02T12:39:00Z</o:LastPrinted>
  <o:Created>2026-01-02T16:10:00Z</o:Created>
  <o:LastSaved>2026-01-02T16:10:00Z</o:LastSaved>
  <o:Pages>9</o:Pages>
  <o:Words>1901</o:Words>
  <o:Characters>12257</o:Characters>
  <o:Company>University Hospitals of North Midlands</o:Company>
  <o:Lines>246</o:Lines>
  <o:Paragraphs>136</o:Paragraphs>
  <o:CharactersWithSpaces>14063</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="nvaf-governance-evidence-v1.2.files/themedata.thmx">
<link rel=colorSchemeMapping
href="nvaf-governance-evidence-v1.2.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-GB</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1040178053 9 0 511 0;}
@font-face
	{font-family:Aptos;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 3 0 0 415 0;}
@font-face
	{font-family:"Aptos Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 3 0 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:18.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
h5
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h6
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#595959;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	mso-style-next:Normal;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	letter-spacing:.75pt;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:18.0pt;
	margin-right:43.2pt;
	margin-bottom:18.0pt;
	margin-left:43.2pt;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-top-alt:solid #0F4761 .5pt;
	mso-border-bottom-alt:solid #0F4761 .5pt;
	padding:0cm;
	mso-padding-alt:10.0pt 0cm 10.0pt 0cm;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.MsoIntenseEmphasis
	{mso-style-priority:21;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	color:#0F4761;
	font-style:italic;}
span.MsoIntenseReference
	{mso-style-priority:32;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	font-variant:small-caps;
	color:#0F4761;
	letter-spacing:.25pt;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 1";
	mso-ansi-font-size:20.0pt;
	mso-bidi-font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 2";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 3";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 4";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;
	font-style:italic;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 5";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 6";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	font-style:italic;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 7";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 8";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 9";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Title;
	mso-ansi-font-size:28.0pt;
	mso-bidi-font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Subtitle;
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	letter-spacing:.75pt;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Quote;
	color:#404040;
	font-style:italic;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Intense Quote";
	color:#0F4761;
	font-style:italic;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-fareast-font-family:Aptos;
	mso-hansi-font-family:Aptos;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:55402103;
	mso-list-template-ids:2070698840;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:132799420;
	mso-list-template-ids:91683016;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:188030205;
	mso-list-template-ids:-1967646190;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:200557032;
	mso-list-template-ids:1614860988;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:373508839;
	mso-list-template-ids:-1454623636;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:465704324;
	mso-list-template-ids:1366731182;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:481194360;
	mso-list-template-ids:-693891604;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7
	{mso-list-id:595600966;
	mso-list-template-ids:165844736;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:619798965;
	mso-list-template-ids:1390939486;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:830144989;
	mso-list-template-ids:-793190728;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:840706130;
	mso-list-template-ids:-131850752;}
@list l10:level1
	{mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level2
	{mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level3
	{mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level4
	{mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level5
	{mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level6
	{mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level7
	{mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level8
	{mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level9
	{mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11
	{mso-list-id:901450960;
	mso-list-template-ids:-1852405178;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:985013011;
	mso-list-template-ids:-864508786;}
@list l12:level1
	{mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level2
	{mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level4
	{mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level7
	{mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13
	{mso-list-id:1367828371;
	mso-list-template-ids:1964012626;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1404722241;
	mso-list-template-ids:198845036;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1445881225;
	mso-list-template-ids:6880832;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16
	{mso-list-id:1505323041;
	mso-list-template-ids:-58544244;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17
	{mso-list-id:1538657684;
	mso-list-template-ids:1260665078;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18
	{mso-list-id:2017993935;
	mso-list-template-ids:-2054526342;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Aptos",sans-serif;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB style='tab-interval:36.0pt;word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:normal;mso-outline-level:1'><b><span
style='font-size:24.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
"Times New Roman";mso-font-kerning:18.0pt;mso-fareast-language:EN-GB'>Anticoagulation
Risk Assessment Tool in Non-Valvular Atrial Fibrillation (NVAF)<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:normal;mso-outline-level:2'><b><span
style='font-size:18.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Governance
Rationale, Evidence Base, and Intended Use<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:115%'><b><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>Author:</span></b><span style='font-size:12.0pt;
line-height:115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'> Dr Prabhath Fernando MBBS MD
FRCP<br>
<b>Associated digital tool:</b> Anticoagulation Risk Assessment Tool in NVAF
(Version 1.2)<br>
<b>Intended setting:</b> NHS secondary care and community practice<br>
<b>Intended users:</b> Clinicians involved in the management of atrial
fibrillation<o:p></o:p></span></p>

<div class=MsoNormal style='margin-bottom:0cm;line-height:115%'><span
style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>

<hr size=2 width="100%" align=left>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>1. Purpose and Scope<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This document describes the
clinical rationale, evidence base, governance considerations, and intended use
of the <b>Anticoagulation Risk Assessment Tool in Non-Valvular Atrial
Fibrillation (NVAF)</b>.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool is designed to
support clinicians in balancing <b>stroke prevention</b> and <b>bleeding risk</b>
when considering oral anticoagulation (OAC) in patients with NVAF, particularly
in <b>older adults and those with frailty or comorbidity</b>.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l9 level1 lfo1;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Uses <b>validated, guideline-endorsed risk
     scores</b> (CHA&#8322;DS&#8322;-VASc and ORBIT) without modification.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l9 level1 lfo1;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Presents stroke and bleeding risks <b>side-by-side</b>
     to support structured clinical judgement.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l9 level1 lfo1;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Provides <b>qualitative net clinical
     benefit statements</b> rather than automated treatment recommendations.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l9 level1 lfo1;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Explicitly signals uncertainty and the
     need for <b>individualised decision-making</b>.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool <b>does not replace</b>
clinical judgement, specialist advice, shared decision-making, or local and
national guidance.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>2. Clinical Background<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Atrial fibrillation (AF) is a
major risk factor for ischaemic stroke, with AF-related strokes associated with
higher mortality and greater long-term disability than non-AF strokes. Oral
anticoagulation substantially reduces stroke risk in NVAF but carries an
inherent risk of bleeding, including major and intracranial <span class=GramE>haemorrhage.</span><o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Clinical decision-making in AF
therefore requires balancing:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l16 level1 lfo2;tab-stops:
     list 36.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Absolute stroke risk without
     anticoagulation</span></b><span style='font-size:12.0pt;line-height:115%;
     font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-fareast-language:EN-GB'>, and<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l16 level1 lfo2;tab-stops:
     list 36.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Absolute bleeding risk with
     anticoagulation</span></b><span style='font-size:12.0pt;line-height:115%;
     font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-fareast-language:EN-GB'>.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This balance is particularly
challenging in:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l0 level1 lfo3;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Older adults<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l0 level1 lfo3;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Patients with frailty<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l0 level1 lfo3;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Those with renal impairment, anaemia, or
     prior bleeding<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l0 level1 lfo3;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Patients with competing risks and limited
     physiological reserve<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Guidelines consistently
recommend assessing <b>both stroke risk and bleeding <span class=GramE>risk<span
style='font-weight:normal'>, but</span></span></b> also emphasise that bleeding
risk scores should be used to <b>identify modifiable risk factors</b>, not as
sole determinants to withhold <span class=GramE>anticoagulation.</span> <o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>In practice, clinicians must
integrate:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l4 level1 lfo4;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Risk scores<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l4 level1 lfo4;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Patient values and preferences<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l4 level1 lfo4;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Frailty, cognition, falls risk, and
     comorbidity<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l4 level1 lfo4;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Anticipated impact of stroke versus
     bleeding on quality of life<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The NVAF Anticoagulation Risk
Assessment Tool was developed to make this reasoning <b>explicit, structured,
and auditable</b>, rather than implicit or inconsistent.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>Representation of older and frail patients in clinical trials<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Although oral anticoagulation
is supported by robust evidence demonstrating stroke risk reduction in
non-valvular atrial fibrillation, it is important to recognise that <b>older
adults and patients with frailty have been under-represented in many landmark
anticoagulation trials</b>.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Pivotal randomised controlled
trials of warfarin and direct oral anticoagulants (DOACs) predominantly
enrolled relatively fit older adults, with <b>limited inclusion of patients
with advanced frailty, multimorbidity, cognitive impairment, high falls risk,
or limited life expectancy</b>. As a result, trial populations may not fully
reflect the complexity of patients encountered in routine clinical practice,
particularly within secondary care and geriatric medicine <span class=GramE>settings.</span>&#8304;
<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Consequently, estimates of
absolute stroke reduction and bleeding risk derived from these trials represent
<b>population averages</b>, and their direct applicability to frail individuals
requires careful clinical interpretation. In frailty, the consequences of both
stroke and major bleeding <span class=GramE>may be amplified,</span> while
competing risks and patient priorities may differ substantially from those
represented in trial cohorts.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This recognised evidence gap
underlines the importance of <b>individualised decision-making</b>, shared
discussion with patients and carers, and cautious application of guideline
recommendations in older and frail populations. The NVAF Anticoagulation Risk
Assessment Tool is designed to support this nuanced judgement rather than to
extrapolate trial findings uncritically to all patients.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>3. Stroke Risk Assessment: CHA&#8322;DS&#8322;-VASc<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool uses the <b>CHA&#8322;DS&#8322;-VASc
score</b> to estimate annual stroke risk in patients with NVAF who are not
anticoagulated.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>CHA&#8322;DS&#8322;-VASc is:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l14 level1 lfo5;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Widely validated across diverse
     populations&#8308;<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l14 level1 lfo5;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Recommended by major international
     guidelines&#8309; &#8310;<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l14 level1 lfo5;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Simple to apply in routine clinical
     practice<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Stroke risk estimates
presented in the tool are derived from large cohort studies and meta-analyses
and are expressed as <b>approximate annual percentages</b>, acknowledging
population-level <span class=GramE>variability.&#8311;</span><o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>In keeping with guideline
recommendations:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l1 level1 lfo6;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>CHA&#8322;DS&#8322;-VASc is used <b>without
     modification</b><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l1 level1 lfo6;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Sex-specific treatment thresholds are
     respected<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l1 level1 lfo6;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>The tool highlights that in frailty, even
     moderate absolute stroke risks may have <b>disproportionately severe
     consequences</b><o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>4. Bleeding Risk Assessment: ORBIT<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>4.1 Rationale for selecting ORBIT<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Several bleeding risk scores
exist, including HAS-BLED, ATRIA, and ORBIT. The present tool uses <b>ORBIT</b>
for the following reasons:<o:p></o:p></span></p>

<ol start=1 type=1>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:115%;mso-list:l10 level1 lfo7;tab-stops:list 36.0pt'><b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'>Predictive performance</span></b><span style='font-size:12.0pt;
     line-height:115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     "Times New Roman";mso-font-kerning:0pt;mso-fareast-language:EN-GB'><br>
     ORBIT has been shown to perform at least as well as, and in some studies
     better than, HAS-BLED for predicting major bleeding in anticoagulated AF <span
     class=GramE>patients.&#8312;</span><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:115%;mso-list:l10 level1 lfo7;tab-stops:list 36.0pt'><b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'>Objective variables</span></b><span style='font-size:12.0pt;
     line-height:115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     "Times New Roman";mso-font-kerning:0pt;mso-fareast-language:EN-GB'><br>
     ORBIT relies predominantly on <b>objective clinical variables</b> (age,
     renal function, haemoglobin/anaemia, prior bleeding, antiplatelet
     therapy), reducing subjectivity and inter-observer variability.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:115%;mso-list:l10 level1 lfo7;tab-stops:list 36.0pt'><b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'>Simplicity and clinical usability</span></b><span style='font-size:
     12.0pt;line-height:115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     "Times New Roman";mso-font-kerning:0pt;mso-fareast-language:EN-GB'><br>
     ORBIT <span class=GramE>avoids</span> labile INR and alcohol-use
     variables, making it particularly suitable in the era of DOACs and in
     settings where warfarin-specific metrics are less <span class=GramE>relevant.&#8313;</span><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:115%;mso-list:l10 level1 lfo7;tab-stops:list 36.0pt'><b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'>Alignment with contemporary practice</span></b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'><br>
     ORBIT was developed and validated in cohorts including patients treated
     with both warfarin and direct oral anticoagulants, making it applicable to
     modern anticoagulation <span class=GramE>strategies.&#8312;</span><o:p></o:p></span></li>
</ol>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>For these reasons, ORBIT was
selected as the bleeding risk estimator in this tool in preference to HAS-BLED,
while recognising that no bleeding score perfectly predicts individual
outcomes.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>4.2 Governance principle<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Consistent with guideline
advice, ORBIT is used in this tool to:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l15 level1 lfo8;tab-stops:
     list 36.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Highlight bleeding risk</span></b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l15 level1 lfo8;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Identify <b>modifiable factors</b><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l15 level1 lfo8;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Inform the clinicianpatient discussion<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>It is <b>not</b> used to
mandate withholding anticoagulation in isolation.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>5. Rationale for Combined Presentation of Stroke and Bleeding Risk<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Clinical guidelines
consistently recommend assessing both <b>stroke risk</b> and <b>bleeding risk</b>
when considering anticoagulation in NVAF. However, in routine practice these
risks are often assessed <b>sequentially or in isolation</b>, rather than being
considered together in a structured manner.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The NVAF Anticoagulation Risk
Assessment Tool presents CHA&#8322;DS&#8322;-VASc and ORBIT outputs <b>side-by-side</b>,
enabling clinicians to directly compare:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l17 level1 lfo9;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Absolute annual stroke risk without
     anticoagulation, and<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l17 level1 lfo9;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Absolute annual major bleeding risk with
     anticoagulation.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Importantly, the tool <b>does
not calculate a single numerical net benefit score</b>. There is currently no
validated, guideline-endorsed method for combining stroke and bleeding risk
scores into a single predictive metric for individual patients. Attempts to do
so risk creating false precision and obscuring <span class=GramE>uncertainty.</span><o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Instead, the tool provides <b>qualitative
net clinical benefit statements</b> that reflect common clinical reasoning
patterns, explicitly signalling when decisions are:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l11 level1 lfo10;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>strongly in favour of anticoagulation,<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l11 level1 lfo10;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>likely to favour anticoagulation with risk
     mitigation, or<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l11 level1 lfo10;tab-stops:
     list 36.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>uncertain and <span class=GramE>preference-sensitive</span></span></b><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'>.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This approach aligns with
guideline emphasis on clinical judgement and shared decision-making rather than
algorithmic decision-<span class=GramE>making.</span> <o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6. Design Principles and Safety Features<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The NVAF Anticoagulation Risk
Assessment Tool was developed using explicit safety-by-design principles
appropriate for clinical decision support.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6.1 Use of validated scores without modification<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>CHA&#8322;DS&#8322;-VASc and
ORBIT are used <b>unchanged</b>, preserving their validated structure,
thresholds, and interpretation.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6.2 Conservative language and uncertainty signalling<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool deliberately avoids
directive language. Outputs are framed using terms such as:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l2 level1 lfo11;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'><span class=GramE>favours</span>
     anticoagulation<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l2 level1 lfo11;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'><span class=GramE>uncertain</span>;
     individualise<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l2 level1 lfo11;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'><span class=GramE>preference</span>-sensitive<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This avoids implying mandatory
treatment decisions and reinforces clinician responsibility.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6.3 Explicit handling of uncertainty<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Where stroke and bleeding
risks are similar in magnitude, or where both risks are high, the tool
explicitly labels the net clinical benefit as <b>uncertain; individualise</b>,
prompting:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l3 level1 lfo12;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>shared decision-making,<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l3 level1 lfo12;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>documentation of rationale,<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l3 level1 lfo12;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>consideration of patient values and goals
     of care.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6.4 Internal consistency checks<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>To prevent contradictory
inputs:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l13 level1 lfo13;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Age &#8805;75 years is defined once within
     CHA&#8322;DS&#8322;-VASc and <b>derived automatically</b> for ORBIT.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l13 level1 lfo13;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>This prevents logically inconsistent age
     band selection across risk scores and reduces user error.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:3'><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>6.5 Reset functionality<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>A reset function is included
to:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l18 level1 lfo14;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Clear all inputs between assessments<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l18 level1 lfo14;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Reduce risk of cross-patient data
     contamination<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l18 level1 lfo14;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Support safe use in busy clinical
     environments<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>7. Interpretation and Clinical Use<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool is intended to be
used as part of a <b>structured clinical assessment</b>, not as a standalone
decision-maker.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Clinicians should:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l8 level1 lfo15;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Use the output to inform discussion with
     patients and carers<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l8 level1 lfo15;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Consider frailty, cognition, falls risk,
     comorbidity, and life expectancy<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l8 level1 lfo15;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Address modifiable bleeding risk factors
     where possible<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l8 level1 lfo15;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Document the reasoning behind
     anticoagulation decisions, particularly where uncertainty exists<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool may be particularly
helpful in:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l5 level1 lfo16;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Older adults with intermediate stroke risk<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l5 level1 lfo16;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Patients with prior bleeding or anaemia<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l5 level1 lfo16;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Situations <span class=GramE>where</span>
     clinicians experience equipoise or disagreement<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>8. Limitations<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>This tool has several
important limitations:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l7 level1 lfo17;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Risk estimates are derived from <b>population-level
     data</b> and do not predict individual outcomes.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l7 level1 lfo17;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Frailty is heterogeneous and not fully
     captured by existing risk scores.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l7 level1 lfo17;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Competing risks and non-cardiovascular
     mortality are not modelled.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l7 level1 lfo17;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>The tool does not replace specialist input
     in complex cases.<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>These limitations are inherent
to current evidence and are explicitly acknowledged within the tools design.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>9. Digital Clinical Safety and Governance Considerations<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The NVAF Anticoagulation Risk
Assessment Tool is a <b>clinical decision support tool</b>, not a medical
device that automates treatment decisions.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>It is intended to:<o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l6 level1 lfo18;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Reduce unwarranted variation<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l6 level1 lfo18;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Promote transparent reasoning<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l6 level1 lfo18;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Support documentation and governance
     review<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Version control is maintained,
and substantive changes are expected to be driven by emerging evidence or
guideline updates rather than cosmetic iteration.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>10. Conclusion<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The <b>Anticoagulation Risk
Assessment Tool in Non-Valvular Atrial Fibrillation (NVAF)</b> has been
developed to support clinicians in navigating the complex balance between
stroke prevention and bleeding risk, particularly in <b>older adults and
patients with frailty</b>, where decision-making is often nuanced and <span
class=GramE>preference-sensitive</span>.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>By combining <b>validated,
guideline-endorsed risk scores</b> (CHA&#8322;DS&#8322;-VASc and ORBIT) without
modification and presenting their outputs side-by-side, the tool promotes
structured clinical reasoning while avoiding false precision or algorithmic
decision-making. Its deliberate use of conservative language, explicit
uncertainty signalling, and safety features reflects both the limitations of
the current evidence base and the realities of contemporary clinical practice.<o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%'><span style='font-size:12.0pt;line-height:
115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-fareast-language:EN-GB'>The tool is intended to <b>support,
not replace, clinical judgement</b>, shared decision-making, and appropriate
documentation. Used within appropriate clinical governance frameworks, it may
help reduce unwarranted variation, enhance transparency of decision-making, and
improve the quality of clinicianpatient discussions regarding anticoagulation
in NVAF.<o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
line-height:115%'><span style='font-size:12.0pt;line-height:115%;font-family:
"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-fareast-language:EN-GB'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
text-align:justify;line-height:115%;mso-outline-level:2'><b><span
style='font-size:18.0pt;line-height:115%;font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
EN-GB'>11. References<o:p></o:p></span></b></p>

<ol start=1 type=1>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Wolf PA, Abbott RD, Kannel WB. Atrial
     fibrillation as an independent risk factor for stroke: the Framingham
     Study. <i>Stroke</i> <span class=GramE>1991;22:983</span>8.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>National Institute for Health and Care
     Excellence. <i>Atrial fibrillation: diagnosis and management (NG196).</i>
     NICE; 2021.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Kirchhof P, Benussi S, Kotecha D, et al.
     2016 ESC Guidelines for the management of atrial fibrillation developed in
     collaboration with EACTS. <span class=SpellE><i>Eur</i></span><i> Heart J</i>
     <span class=GramE>2016;37:2893</span>962.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Lip GYH, <span class=SpellE>Nieuwlaat</span>
     R, Pisters R, et al. Refining clinical risk stratification for predicting
     stroke and thromboembolism in atrial fibrillation using a novel risk
     factor-based approach: the Euro Heart Survey. <i>Chest</i> <span
     class=GramE>2010;137:263</span>72.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>January CT, Wann LS, Calkins H, et al.
     2019 AHA/ACC/HRS focused update of the 2014 guideline for the management
     of patients with atrial fibrillation. <i>Circulation</i> 2019;<span
     class=GramE>140:e</span>12551.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span class=SpellE><span style='font-size:12.0pt;line-height:
     115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Hindricks</span></span><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'> G, <span class=SpellE>Potpara</span> T, Dagres N, et al. 2020 ESC
     Guidelines for the diagnosis and management of atrial fibrillation. <span
     class=SpellE><i>Eur</i></span><i> Heart J</i> <span class=GramE>2021;42:373</span>498.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Friberg L, Rosenqvist M, Lip GYH.
     Evaluation of risk stratification schemes for ischaemic stroke and
     bleeding in atrial fibrillation. <i>Circulation</i> <span class=GramE>2012;125:2298</span>307.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>OBrien EC, Simon DN, Thomas LE, et al.
     The ORBIT bleeding score: a simple bedside score to assess bleeding risk
     in atrial fibrillation. <span class=SpellE><i>Eur</i></span><i> Heart J</i>
     <span class=GramE>2015;36:3258</span>64.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Lip GYH, Banerjee A, <span class=SpellE>Boriani</span>
     G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline
     and expert panel report. <i>Chest</i> <span class=GramE>2018;154:1121</span>201.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Kakkar AK, Mueller I, <span class=SpellE>Bassand</span>
     JP, et al. Risk profiles and antithrombotic treatment of patients newly
     diagnosed with atrial fibrillation at risk of stroke: GARFIELD-AF
     Registry. <i>Lancet</i> <span class=GramE>2013;382:1760</span>8.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span class=SpellE><span style='font-size:12.0pt;line-height:
     115%;font-family:"Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-fareast-language:EN-GB'>Sjalander</span></span><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:
     EN-GB'> S, Sjgren V, <span class=SpellE>Renlund</span> H, et al.
     Dabigatran, rivaroxaban and apixaban versus warfarin in atrial
     fibrillation patients &#8805;75 years. <i>Heart</i> <span class=GramE>2018;104:1868</span>74.<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     text-align:justify;line-height:115%;mso-list:l12 level1 lfo19;tab-stops:
     list 36.0pt'><span style='font-size:12.0pt;line-height:115%;font-family:
     "Calibri",sans-serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
     0pt;mso-fareast-language:EN-GB'>Singer DE, Chang Y, Borowsky LH, et al. A
     new risk scheme to predict ischemic stroke and other thromboembolism in
     atrial fibrillation: the ATRIA study stroke risk score. <i>J Am Heart
     Assoc</i> 2013;<span class=GramE>2:e</span>000250.<o:p></o:p></span></li>
</ol>

<p class=MsoNormal style='text-align:justify;line-height:115%'><span
style='font-family:"Calibri",sans-serif'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>

